Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mairah T Khan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|January 26, 2022
Development and validation of a hypoxia-associated signature for lung adenocarcinomaBrian Lane, Mairah T Khan, Ananya Choudhury, et al.
The Journal of Clinical Investigation|May 4, 2026
Divergent Macrophage-Regulated T cell States Determine Response to Bacillus Calmette-Guérin vaccine in High-Risk Bladder CancerRyan J Brown, Mairah T Khan, Andrew J Houston, et al.
Radiation Research|February 12, 2021
Developing Tumor Radiosensitivity Signatures Using LncRNAsMairah T Khan, Lingjian Yang, Elisabet More, et al.
British Journal of Cancer|April 13, 2021
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancerMairah T Khan, Joely J Irlam-Jones, Ronnie Rodrigues Pereira, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|January 26, 2022
Development and validation of a hypoxia-associated signature for lung adenocarcinomaBrian Lane, Mairah T Khan, Ananya Choudhury, et al.
The Journal of Clinical Investigation|May 4, 2026
Divergent Macrophage-Regulated T cell States Determine Response to Bacillus Calmette-Guérin vaccine in High-Risk Bladder CancerRyan J Brown, Mairah T Khan, Andrew J Houston, et al.
Radiation Research|February 12, 2021
Developing Tumor Radiosensitivity Signatures Using LncRNAsMairah T Khan, Lingjian Yang, Elisabet More, et al.
British Journal of Cancer|April 13, 2021
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancerMairah T Khan, Joely J Irlam-Jones, Ronnie Rodrigues Pereira, et al.
Pageof 1